NASDAQ:KLRS | Profit Breakdown | Kalaris Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2019-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$12.39M-$11.52M
2026-03-31-$11.83M-$10.86M
2025-12-31-$10.8M-$10M
2025-09-30-$12.74M-$11.89M
2025-06-30-$12.26M-$11.35M
2025-03-31-$10.35M-$10.2M
2024-12-31-$7.13M-$22.03M
2024-09-30-$37.85M-$38.08M
2024-06-30-$4.19M-$5.65M
2024-03-31-$2.56M-$3.41M
2023-12-31-$62.41M-$59.82M-$59.7M
2023-09-30-$46.96M-$44.27M-$44.27M
2023-06-30-$47.3M-$45.27M-$45.27M
2023-03-31-$43.23M-$41.18M
2022-12-31-$40.43M-$38.55M-$38.14M
2022-09-30-$42.95M-$42.07M-$42.07M
2022-06-30-$44.62M-$44.49M-$44.64M
2022-03-31-$43.19M-$43.86M-$43.86M
2021-12-31-$55.8M-$56.93M-$57.94M
2021-09-30-$45.5M-$45.51M-$45.51M
2021-06-30-$37.66M-$37.59M-$37.59M
2021-03-31-$30.86M-$30.92M
2020-12-31-$25.42M-$25.2M
2020-09-30-$23.9M-$23.61M
2020-06-30-$12.15M-$11.63M
2020-03-31-$9.84M-$9.34M
2019-12-31$0.00-$9.51M-$8.74M
2019-09-30-$8.48M-$7.27M
2019-06-30-$5.95M-$5.3M
2019-03-31-$2.52M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$46.15M-$43.44M-$43.44M
2024-12-31-$51.73M-$69.17M-$69.17M
2023-12-31-$199.9M-$190.54M-$190.42M
2022-12-31-$171.2M-$168.98M-$168.71M
2021-12-31-$169.82M-$170.96M-$171.96M
2020-12-31-$71.31M-$69.78M-$69.78M
2019-12-31$165,000.00-$26.7M-$23.84M-$23.84M